Cite
HARVARD Citation
Azoulay, M. et al. (2020). A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes. Neuro-oncology. 22 (8), pp. 1182-1189. [Online].